Insulet revenue and financials

PODD · NASDAQ · USD

$135.59−0.02%−$0.03

Close · October 6, 2026

In the fiscal year ended December 2025, Insulet reported revenue of $2.71B (+30.73% year over year). Net income was $247.1M, a net margin of 9.1%.

Annual revenue · 2025: $2.71B

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	802	762	784	706	649	569	598	544	489	442	510	433
Cost of revenue	239	233	215	196	197	160	180	167	144	135	149	141
Gross profit	563	529	569	510	452	409	417	377	344	307	360	291
Selling, general and administrative	345	317	331	315	258	261	261	234	223	200	213	181
Research and development	88.1	89.7	90.9	77.2	73.4	59.6	60.6	54.9	53.9	50.2	42.0	57.8
Operating income	130	122	146	118	121	88.8	95.9	88.1	68.0	56.9	106	52.9
EBIT	130	122	146	118	121	88.8	95.9	88.1	68.0	56.9	106	52.9
EBITDA	156	148	171	140	143	111	117	109	87.2	75.7	124	71.6
Interest expense	13.5	14.7	14.9	15.6	19.6	9.2	8.6	12.4	11.0	10.7	6.7	10.4
Pre-tax income	119	113	140	123	28.4	48.1	111	82.9	51.1	54.9	108	53.7
Income tax	23.7	21.9	38.5	35.2	5.9	12.7	10.7	5.4	-138	3.4	4.5	1.8
Net income	95.0	91.1	102	87.6	22.5	35.4	101	77.5	189	51.5	103	51.9
Net income to common shareholders	95.0	91.1	102	87.6	22.5	35.4	101	77.5	189	51.5	103	51.9
Basic EPS	1.37	1.30	1.44	1.24	0.32	0.50	1.44	1.11	2.69	0.74	1.48	0.74
Diluted EPS	1.37	1.30	1.44	1.24	0.32	0.50	1.39	1.08	2.59	0.73	1.48	0.74
Average shares (basic)	69.3	70.0	70.4	70.4	70.4	70.3	70.2	70.1	70.1	70.0	69.9	69.8
Average shares (diluted)	69.4	70.2	70.7	70.7	70.7	74.1	74.1	74.0	73.8	73.7	73.6	73.6